Drugs that contain Insulin Glulisine Recombinant
1. Apidra patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6221633 | SANOFI AVENTIS US | Insulin derivatives having a rapid onset of action |
Jun, 2018
(5 years ago) | |
| US7452860 | SANOFI AVENTIS US | Zinc-free and low-zinc insulin preparations having improved stability |
Mar, 2022
(2 years ago) | |
| US7696162 | SANOFI AVENTIS US | Zinc-free and low-zinc insulin preparations having improved stability |
Mar, 2022
(2 years ago) | |
| US6960561 | SANOFI AVENTIS US | Zinc-free and low-zinc insulin preparations having improved stability |
Jan, 2023
(1 year, 3 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Oct 24, 2011 |
Market Authorisation Date: 16 April, 2004
Treatment: Method of treating a patient suffering from diabetes mellitus
Dosage: INJECTABLE;IV (INFUSION)-SC
APIDRA family patents
2. Apidra Solostar patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6221633 | SANOFI AVENTIS US | Insulin derivatives having a rapid onset of action |
Jun, 2018
(5 years ago) | |
| US7452860 | SANOFI AVENTIS US | Zinc-free and low-zinc insulin preparations having improved stability |
Mar, 2022
(2 years ago) | |
| US7696162 | SANOFI AVENTIS US | Zinc-free and low-zinc insulin preparations having improved stability |
Mar, 2022
(2 years ago) | |
| US6960561 | SANOFI AVENTIS US | Zinc-free and low-zinc insulin preparations having improved stability |
Jan, 2023
(1 year, 3 months ago) | |
| US9775954 | SANOFI AVENTIS US | Pen-type injector |
Mar, 2024
(2 months ago) | |
| US9827379 | SANOFI AVENTIS US | Drive mechanisms suitable for use in drug delivery devices |
Mar, 2024
(2 months ago) | |
| US9408979 | SANOFI AVENTIS US | Pen-type injector |
Mar, 2024
(2 months ago) | |
| US8603044 | SANOFI AVENTIS US | Pen-type injector |
Mar, 2024
(2 months ago) | |
| US9610409 | SANOFI AVENTIS US | Drive mechanisms suitable for use in drug delivery devices |
Mar, 2024
(2 months ago) | |
| US9604008 | SANOFI AVENTIS US | Drive mechanisms suitable for use in drug delivery devices |
Mar, 2024
(2 months ago) | |
| US9526844 | SANOFI AVENTIS US | Pen-type injector |
Mar, 2024
(2 months ago) | |
| US9233211 | SANOFI AVENTIS US | Relating to a pen-type injector |
Mar, 2024
(2 months ago) | |
| US8556864 | SANOFI AVENTIS US | Drive mechanisms suitable for use in drug delivery devices |
Mar, 2024
(2 months ago) | |
| US9011391 | SANOFI AVENTIS US | Pen-type injector |
Mar, 2024
(a month ago) | |
| US8992486 | SANOFI AVENTIS US | Pen-type injector |
Jun, 2024
(a month from now) | |
| US9604009 | SANOFI AVENTIS US | Drive mechanisms suitable for use in drug delivery devices |
Aug, 2024
(3 months from now) | |
| US9533105 | SANOFI AVENTIS US | Drive mechanisms suitable for use in drug delivery devices |
Aug, 2024
(3 months from now) | |
| US9623189 | SANOFI AVENTIS US | Relating to drive mechanisms suitable for use in drug delivery devices |
Aug, 2024
(3 months from now) | |
| US9561331 | SANOFI AVENTIS US | Drive mechanisms suitable for use in drug delivery devices |
Aug, 2024
(3 months from now) | |
| US8512297 | SANOFI AVENTIS US | Pen-type injector |
Sep, 2024
(4 months from now) | |
| US8679069 | SANOFI AVENTIS US | Pen-type injector |
Apr, 2025
(11 months from now) | |
| US7918833 | SANOFI AVENTIS US | Pen-type injector |
Sep, 2027
(3 years from now) | |
| US9717852 | SANOFI AVENTIS US | Cartridge holder and pen-type injector |
Apr, 2033
(8 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Oct 24, 2011 |
Market Authorisation Date: 16 April, 2004
Treatment: Method of treating a patient suffering from diabetes mellitus; Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a rotating drive sleeve; Improvement in glyce...
Dosage: INJECTABLE;SUBCUTANEOUS
APIDRA SOLOSTAR family patents